Therapeutic Prospects in Preeclampsia - A Mini-Review

Author(s): N.S. Das, S.T. Dheen, E.A. Ling, B.H. Bay, D.K. Srinivasan*.

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 25 , 2019

  Journal Home
Translate in Chinese

Abstract:

Background: Preeclapmsia (PE) is characterized by early onset symptoms such as elevated blood pressure, proteinuria and edema in the pregnant woman, and may result in seizures in the affected female. Currently, there are no therapeutic drugs available to treat this condition, but there are interventions to regulate the symptoms based on the gestational period of the fetus, although the largely favored option is delivery of the fetus and placenta.

Objective: A search for biomolecules associated with PE was conducted so as to identify diagnostic markers and therapeutic leads.

Results: The literature search resulted in the identification of biomolecules such as Corin and Placental Protein 13 (PP13), among others that are associated with PE. Thereby, giving an insight into the various mechanistic pathways involved in the causation of PE. However, it is also evident that PE cannot be solely attributed to any single mechanism but is due to an interplay of different factors that have led to the development of this disease condition.

Conclusion: The identified biomarkers would ultimately help in understanding this complex disease and perhaps lead to the discovery of potential effective molecular targets for clinical trials, thereby providing a valuable therapeutic option for affected pregnant women.

Keywords: Preeclampsia, hypertension, biomarkers, corin, placental protein 13, adenosine.

[1]
Roberts, J.M. Preeclampsia: what we know and what we do not know. Semin. Perinatol., 2000, 24(1), 24-28.
[http://dx.doi.org/10.1016/S0146-0005(00)80050-6] [PMID: 10709854]
[2]
Saleh, A.A.; Bottoms, S.F.; Welch, R.A.; Ali, A.M.; Mariona, F.G.; Mammen, E.F. Preeclampsia, delivery, and the hemostatic system. Am. J. Obstet. Gynecol., 1987, 157(2), 331-336.
[http://dx.doi.org/10.1016/S0002-9378(87)80163-1] [PMID: 2441602]
[3]
Roberts, J.M.; Taylor, R.N.; Musci, T.J.; Rodgers, G.M.; Hubel, C.A.; McLaughlin, M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol., 1990, 32(3), 1200-1204.
[4]
Sibai, B.; Dekker, G.; Kupferminc, M. Pre-eclampsia. Lancet, 2005, 365(9461), 785-799.
[http://dx.doi.org/10.1016/S0140-6736(05)17987-2] [PMID: 15733721]
[5]
Tomimatsu, T.; Mimura, K.; Endo, M.; Kumasawa, K.; Kimura, T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens. Res., 2017, 40(4), 305-310.
[http://dx.doi.org/10.1038/hr.2016.152] [PMID: 27829661]
[6]
Chen, C.W.; Jaffe, I.Z.; Karumanchi, S.A. Pre-eclampsia and cardiovascular disease. Cardiovasc. Res., 2014, 101(4), 579-586.
[http://dx.doi.org/10.1093/cvr/cvu018] [PMID: 24532051]
[7]
Ness, R.B.; Sibai, B.M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am. J. Obstet. Gynecol., 2006, 195(1), 40-49.
[http://dx.doi.org/10.1016/j.ajog.2005.07.049] [PMID: 16813742]
[8]
Odegård, R.A.; Vatten, L.J.; Nilsen, S.T.; Salvesen, K.A.; Austgulen, R. Preeclampsia and fetal growth. Obstet. Gynecol., 2000, 96(6), 950-955.
[PMID: 11084184]
[9]
Dhariwal, N.K.; Lynde, G.C. Update in the Management of Patients with Preeclampsia. Anesthesiol. Clin., 2017, 35(1), 95-106.
[http://dx.doi.org/10.1016/j.anclin.2016.09.009] [PMID: 28131123]
[10]
Hofmeyr, R.; Matjila, M.; Dyer, R. Preeclampsia in 2017: obstetric and anaesthesia management. Best Pract. Res. Clin. Anaesthesiol., 2017, 31(1), 125-138.
[http://dx.doi.org/10.1016/j.bpa.2016.12.002] [PMID: 28625300]
[11]
Genbacev, O.; Zhou, Y.; Ludlow, J.W.; Fisher, S.J. Regulation of human placental development by oxygen tension. Science, 1997, 277(5332), 1669-1672.
[http://dx.doi.org/10.1126/science.277.5332.1669] [PMID: 9287221]
[12]
Huppertz, B. The anatomy of the normal placenta. J. Clin. Pathol., 2008, 61(12), 1296-1302.
[http://dx.doi.org/10.1136/jcp.2008.055277] [PMID: 18755720]
[13]
Nagar, T.; Sharma, D.; Choudhary, M.; Khoiwal, S.; Nagar, R.P.; Pandita, A. The Role of Uterine and Umbilical Arterial Doppler in High-risk Pregnancy: A Prospective Observational Study from India. Clin. Med. Insights Reprod. Health, 2015, 9, 1-5.
[http://dx.doi.org/10.4137/CMRH.S24048] [PMID: 25922590]
[14]
Baschat, A.A.; Galan, H.L.; Bhide, A.; Berg, C.; Kush, M.L.; Oepkes, D.; Thilaganathan, B.; Gembruch, U.; Harman, C.R. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results. Ultrasound Obstet. Gynecol., 2006, 27(1), 41-47.
[http://dx.doi.org/10.1002/uog.2657] [PMID: 16323151]
[15]
Oyston, C.J.; Stanley, J.L.; Baker, P.N. Potential targets for the treatment of preeclampsia. Expert Opin. Ther. Targets, 2015, 19(11), 1517-1530.
[http://dx.doi.org/10.1517/14728222.2015.1088004] [PMID: 26389556]
[16]
Saito, S.; Sakai, M.; Sasaki, Y.; Nakashima, A.; Shiozaki, A. Inadequate tolerance induction may induce pre-eclampsia. J. Reprod. Immunol., 2007, 76(1-2), 30-39.
[http://dx.doi.org/10.1016/j.jri.2007.08.002] [PMID: 17935792]
[17]
Robillard, P-Y.; Dekker, G.; Chaouat, G.; Hulsey, T.C.; Saftlas, A. Epidemiological studies on primipaternity and immunology in preeclampsia--a statement after twelve years of workshops. J. Reprod. Immunol., 2011, 89(2), 104-117.
[http://dx.doi.org/10.1016/j.jri.2011.02.003] [PMID: 21543120]
[18]
Feeney, J.G.; Scott, J.S. Pre-eclampsia and changed paternity. Eur. J. Obstet. Gynecol. Reprod. Biol., 1980, 11(1), 35-38.
[http://dx.doi.org/10.1016/0028-2243(80)90051-9] [PMID: 7193608]
[19]
Rowe, J.H.; Ertelt, J.M.; Xin, L.; Way, S.S. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature, 2012, 490(7418), 102-106.
[http://dx.doi.org/10.1038/nature11462] [PMID: 23023128]
[20]
Robertson, S.A.; Guerin, L.R.; Bromfield, J.J.; Branson, K.M.; Ahlström, A.C.; Care, A.S. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod., 2009, 80(5), 1036-1045.
[http://dx.doi.org/10.1095/biolreprod.108.074658] [PMID: 19164169]
[21]
Robertson, S.A.; Guerin, L.R.; Moldenhauer, L.M.; Hayball, J.D. Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid. J. Reprod. Immunol., 2009, 83(1-2), 109-116.
[http://dx.doi.org/10.1016/j.jri.2009.08.003] [PMID: 19875178]
[22]
Shima, T.; Inada, K.; Nakashima, A.; Ushijima, A.; Ito, M.; Yoshino, O.; Saito, S. Paternal antigen-specific proliferating regulatory T cells are increased in uterine-draining lymph nodes just before implantation and in pregnant uterus just after implantation by seminal plasma-priming in allogeneic mouse pregnancy. J. Reprod. Immunol., 2015, 108, 72-82.
[http://dx.doi.org/10.1016/j.jri.2015.02.005] [PMID: 25817463]
[23]
Aluvihare, V.R.; Kallikourdis, M.; Betz, A.G.; Regulatory, T. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol., 2004, 5(3), 266-271.
[http://dx.doi.org/10.1038/ni1037] [PMID: 14758358]
[24]
Sasaki, Y.; Darmochwal-Kolarz, D.; Suzuki, D.; Sakai, M.; Ito, M.; Shima, T.; Shiozaki, A.; Rolinski, J.; Saito, S. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin. Exp. Immunol., 2007, 149(1), 139-145.
[http://dx.doi.org/10.1111/j.1365-2249.2007.03397.x] [PMID: 17459078]
[25]
Rahimzadeh, M.; Norouzian, M.; Arabpour, F.; Naderi, N. Regulatory T-cells and preeclampsia: an overview of literature. Expert Rev. Clin. Immunol., 2016, 12(2), 209-227.
[http://dx.doi.org/10.1586/1744666X.2016.1105740] [PMID: 26580672]
[26]
Dekker, G.; Robillard, P.Y.; Roberts, C. The etiology of preeclampsia: the role of the father. J. Reprod. Immunol., 2011, 89(2), 126-132.
[http://dx.doi.org/10.1016/j.jri.2010.12.010] [PMID: 21529966]
[27]
Kanagalingam, M.G.; Forouhi, N.G.; Greer, I.A.; Sattar, N. Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG, 2005, 112(10), 1431-1433.
[http://dx.doi.org/10.1111/j.1471-0528.2005.00685.x] [PMID: 16167951]
[28]
Salihu, H.M.; De La Cruz, C.; Rahman, S.; August, E.M. Does maternal obesity cause preeclampsia? A systematic review of the evidence. Minerva Ginecol., 2012, 64(4), 259-280.
[PMID: 22728572]
[29]
Rosenberg, T.J.; Garbers, S.; Lipkind, H.; Chiasson, M.A. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am. J. Public Health, 2005, 95(9), 1545-1551.
[http://dx.doi.org/10.2105/AJPH.2005.065680] [PMID: 16118366]
[30]
Molvarec, A.; Shiozaki, A.; Ito, M.; Toldi, G.; Stenczer, B.; Szarka, A.; Nakashima, A.; Vásárhelyi, B.; Rigó, J., Jr; Saito, S. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia. J. Reprod. Immunol., 2011, 91(1-2), 56-63.
[http://dx.doi.org/10.1016/j.jri.2011.03.012] [PMID: 21763002]
[31]
Jolly, M.C.; Sebire, N.J.; Harris, J.P.; Regan, L.; Robinson, S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol., 2003, 111(1), 9-14.
[http://dx.doi.org/10.1016/S0301-2115(03)00154-4] [PMID: 14557004]
[32]
Gilbert, J.S.; Ryan, M.J.; LaMarca, B.B.; Sedeek, M.; Murphy, S.R.; Granger, J.P. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol., 2008, 294, 541-550.
[http://dx.doi.org/10.1152/ajpheart.01113.2007]
[33]
Poston, L. Endothelial dysfunction in pre-eclampsia. Pharmacol. Rep., 2006, 58(Suppl.), 69-74.
[PMID: 17332674]
[34]
Roberts, J.M.; Taylor, R.N.; Goldfien, A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am. J. Hypertens., 1991, 4(8), 700-708.
[http://dx.doi.org/10.1093/ajh/4.8.700] [PMID: 1930853]
[35]
McCarthy, J.F.; Misra, D.N.; Roberts, J.M. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am. J. Obstet. Gynecol., 1999, 180(3 Pt 1), 731-736.
[http://dx.doi.org/10.1016/S0002-9378(99)70280-2] [PMID: 10076155]
[36]
Meekins, J.W. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol., 1995, 102(10), 842-843.
[http://dx.doi.org/10.1111/j.1471-0528.1995.tb10859.x] [PMID: 7547749]
[37]
Santangeli, L.; Sattar, N.; Huda, S.S. Impact of maternal obesity on perinatal and childhood outcomes. Best Pract. Res. Clin. Obstet. Gynaecol., 2015, 29(3), 438-448.
[http://dx.doi.org/10.1016/j.bpobgyn.2014.10.009] [PMID: 25497183]
[38]
Sibai, B.M. Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J. Matern. Fetal Med., 2000, 9(1), 62-65.
[http://dx.doi.org/10.1002/(SICI)1520-6661(200001/02)9:1<62:AID-MFM13>3.0.CO;2-6] [PMID: 10757438]
[39]
Zhe, C.; Ni, Y. Women’s Experiences of Preeclampsia in Pregnancy.. Student Thesis, Lishui University: China,, 2018.www.divaportal.org/smash/get/diva2:1222408/FULLTEXT01.pdf
[40]
Dhyani; Mahantashetti, N. S.; Ganachari, M.; Kambar, S.; Ghatnatti, V. Awareness of gestational diabetes mellitus among pregnant women attending a tertiary health center. Indian J. Heal. Sci. Biomed. Res., 2018, 11(1), 51-55.
[http://dx.doi.org/10.4103/kleuhsj.kleuhsj_130_17]
[41]
Wilkinson, J.; Cole, G. Preeclampsia knowledge among women in Utah. Hypertens. Pregnancy, 2018, 37(1), 18-24.
[http://dx.doi.org/10.1080/10641955.2017.1397691] [PMID: 29140734]
[42]
Cox, L.S.; Redman, C. The role of cellular senescence in ageing of the placenta. Placenta, 2017, 52, 139-145.
[http://dx.doi.org/10.1016/j.placenta.2017.01.116] [PMID: 28131318]
[43]
Brosens, J.J.; Parker, M.G.; McIndoe, A.; Pijnenborg, R.; Brosens, I.A. A role for menstruation in preconditioning the uterus for successful pregnancy. Am. J. Obstet. Gynecol., 2009, 200(6), 615.e1-615.e6.
[http://dx.doi.org/10.1016/j.ajog.2008.11.037] [PMID: 19136085]
[44]
Kassebaum, N.J.; Bertozzi-Villa, A.; Coggeshall, M.S.; Shackelford, K.A.; Steiner, C.; Heuton, K.R.; Gonzalez-Medina, D.; Barber, R.; Huynh, C.; Dicker, D.; Templin, T.; Wolock, T.M.; Ozgoren, A.A.; Abd-Allah, F.; Abera, S.F.; Abubakar, I.; Achoki, T.; Adelekan, A.; Ademi, Z.; Adou, A.K.; Adsuar, J.C.; Agardh, E.E.; Akena, D.; Alasfoor, D.; Alemu, Z.A.; Alfonso-Cristancho, R.; Alhabib, S.; Ali, R.; Al Kahbouri, M.J.; Alla, F.; Allen, P.J.; AlMazroa, M.A.; Alsharif, U.; Alvarez, E.; Alvis-Guzmán, N.; Amankwaa, A.A.; Amare, A.T.; Amini, H.; Ammar, W.; Antonio, C.A.; Anwari, P.; Arnlöv, J.; Arsenijevic, V.S.; Artaman, A.; Asad, M.M.; Asghar, R.J.; Assadi, R.; Atkins, L.S.; Badawi, A.; Balakrishnan, K.; Basu, A.; Basu, S.; Beardsley, J.; Bedi, N.; Bekele, T.; Bell, M.L.; Bernabe, E.; Beyene, T.J.; Bhutta, Z.; Bin Abdulhak, A.; Blore, J.D.; Basara, B.B.; Bose, D.; Breitborde, N.; Cárdenas, R.; Castañeda-Orjuela, C.A.; Castro, R.E.; Catalá-López, F.; Cavlin, A.; Chang, J.C.; Che, X.; Christophi, C.A.; Chugh, S.S.; Cirillo, M.; Colquhoun, S.M.; Cooper, L.T.; Cooper, C.; da Costa Leite, I.; Dandona, L.; Dandona, R.; Davis, A.; Dayama, A.; Degenhardt, L.; De Leo, D.; del Pozo-Cruz, B.; Deribe, K.; Dessalegn, M.; deVeber, G.A.; Dharmaratne, S.D.; Dilmen, U.; Ding, E.L.; Dorrington, R.E.; Driscoll, T.R.; Ermakov, S.P.; Esteghamati, A.; Faraon, E.J.; Farzadfar, F.; Felicio, M.M.; Fereshtehnejad, S.M.; de Lima, G.M.; Forouzanfar, M.H.; França, E.B.; Gaffikin, L.; Gambashidze, K.; Gankpé, F.G.; Garcia, A.C.; Geleijnse, J.M.; Gibney, K.B.; Giroud, M.; Glaser, E.L.; Goginashvili, K.; Gona, P.; González-Castell, D.; Goto, A.; Gouda, H.N.; Gugnani, H.C.; Gupta, R.; Gupta, R.; Hafezi-Nejad, N.; Hamadeh, R.R.; Hammami, M.; Hankey, G.J.; Harb, H.L.; Havmoeller, R.; Hay, S.I.; Pi, I.B.; Hoek, H.W.; Hosgood, H.D.; Hoy, D.G.; Husseini, A.; Idrisov, B.T.; Innos, K.; Inoue, M.; Jacobsen, K.H.; Jahangir, E.; Jee, S.H.; Jensen, P.N.; Jha, V.; Jiang, G.; Jonas, J.B.; Juel, K.; Kabagambe, E.K.; Kan, H.; Karam, N.E.; Karch, A.; Karema, C.K.; Kaul, A.; Kawakami, N.; Kazanjan, K.; Kazi, D.S.; Kemp, A.H.; Kengne, A.P.; Kereselidze, M.; Khader, Y.S.; Khalifa, S.E.; Khan, E.A.; Khang, Y.H.; Knibbs, L.; Kokubo, Y.; Kosen, S.; Defo, B.K.; Kulkarni, C.; Kulkarni, V.S.; Kumar, G.A.; Kumar, K.; Kumar, R.B.; Kwan, G.; Lai, T.; Lalloo, R.; Lam, H.; Lansingh, V.C.; Larsson, A.; Lee, J.T.; Leigh, J.; Leinsalu, M.; Leung, R.; Li, X.; Li, Y.; Li, Y.; Liang, J.; Liang, X.; Lim, S.S.; Lin, H.H.; Lipshultz, S.E.; Liu, S.; Liu, Y.; Lloyd, B.K.; London, S.J.; Lotufo, P.A.; Ma, J.; Ma, S.; Machado, V.M.; Mainoo, N.K.; Majdan, M.; Mapoma, C.C.; Marcenes, W.; Marzan, M.B.; Mason-Jones, A.J.; Mehndiratta, M.M.; Mejia-Rodriguez, F.; Memish, Z.A.; Mendoza, W.; Miller, T.R.; Mills, E.J.; Mokdad, A.H.; Mola, G.L.; Monasta, L.; de la Cruz Monis, J.; Hernandez, J.C.; Moore, A.R.; Moradi-Lakeh, M.; Mori, R.; Mueller, U.O.; Mukaigawara, M.; Naheed, A.; Naidoo, K.S.; Nand, D.; Nangia, V.; Nash, D.; Nejjari, C.; Nelson, R.G.; Neupane, S.P.; Newton, C.R.; Ng, M.; Nieuwenhuijsen, M.J.; Nisar, M.I.; Nolte, S.; Norheim, O.F.; Nyakarahuka, L.; Oh, I.H.; Ohkubo, T.; Olusanya, B.O.; Omer, S.B.; Opio, J.N.; Orisakwe, O.E.; Pandian, J.D.; Papachristou, C.; Park, J.H.; Caicedo, A.J.; Patten, S.B.; Paul, V.K.; Pavlin, B.I.; Pearce, N.; Pereira, D.M.; Pesudovs, K.; Petzold, M.; Poenaru, D.; Polanczyk, G.V.; Polinder, S.; Pope, D.; Pourmalek, F.; Qato, D.; Quistberg, D.A.; Rafay, A.; Rahimi, K.; Rahimi-Movaghar, V. ur Rahman, S.; Raju, M.; Rana, S.M.; Refaat, A.; Ronfani, L.; Roy, N.; Pimienta, T.G.; Sahraian, M.A.; Salomon, J.A.; Sampson, U.; Santos, I.S.; Sawhney, M.; Sayinzoga, F.; Schneider, I.J.; Schumacher, A.; Schwebel, D.C.; Seedat, S.; Sepanlou, S.G.; Servan-Mori, E.E.; Shakh-Nazarova, M.; Sheikhbahaei, S.; Shibuya, K.; Shin, H.H.; Shiue, I.; Sigfusdottir, I.D.; Silberberg, D.H.; Silva, A.P.; Singh, J.A.; Skirbekk, V.; Sliwa, K.; Soshnikov, S.S.; Sposato, L.A.; Sreeramareddy, C.T.; Stroumpoulis, K.; Sturua, L.; Sykes, B.L.; Tabb, K.M.; Talongwa, R.T.; Tan, F.; Teixeira, C.M.; Tenkorang, E.Y.; Terkawi, A.S.; Thorne-Lyman, A.L.; Tirschwell, D.L.; Towbin, J.A.; Tran, B.X.; Tsilimbaris, M.; Uchendu, U.S.; Ukwaja, K.N.; Undurraga, E.A.; Uzun, S.B.; Vallely, A.J.; van Gool, C.H.; Vasankari, T.J.; Vavilala, M.S.; Venketasubramanian, N.; Villalpando, S.; Violante, F.S.; Vlassov, V.V.; Vos, T.; Waller, S.; Wang, H.; Wang, L.; Wang, X.; Wang, Y.; Weichenthal, S.; Weiderpass, E.; Weintraub, R.G.; Westerman, R.; Wilkinson, J.D.; Woldeyohannes, S.M.; Wong, J.Q.; Wordofa, M.A.; Xu, G.; Yang, Y.C.; Yano, Y.; Yentur, G.K.; Yip, P.; Yonemoto, N.; Yoon, S.J.; Younis, M.Z.; Yu, C.; Jin, K.Y.; El Sayed Zaki, M.; Zhao, Y.; Zheng, Y.; Zhou, M.; Zhu, J.; Zou, X.N.; Lopez, A.D.; Naghavi, M.; Murray, C.J.; Lozano, R. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2014, 384(9947), 980-1004.
[http://dx.doi.org/10.1016/S0140-6736(14)60696-6] [PMID: 24797575]
[45]
Ghulmiyyah, L.; Sibai, B. Maternal mortality from preeclampsia/eclampsia. Semin. Perinatol., 2012, 36(1), 56-59.
[http://dx.doi.org/10.1053/j.semperi.2011.09.011] [PMID: 22280867]
[46]
Dennis, A.T. Transthoracic echocardiography in obstetric anaesthesia and obstetric critical illness. Int. J. Obstet. Anesth., 2011, 20(2), 160-168.
[http://dx.doi.org/10.1016/j.ijoa.2010.11.007] [PMID: 21315578]
[47]
American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy. Obstet. Gynecol., 2013, 122(5), 1122-1131.
[http://dx.doi.org/10.1097/01.AOG.0000437382.03963.88] [PMID: 24150027]
[48]
Wallace, D.H.; Leveno, K.J.; Cunningham, F.G.; Giesecke, A.H.; Shearer, V.E.; Sidawi, J.E. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet. Gynecol., 1995, 86(2), 193-199.
[http://dx.doi.org/10.1016/0029-7844(95)00139-I] [PMID: 7617349]
[49]
Parthasarathy, S.; Kumar, V.R.H.; Sripriya, R.; Ravishankar, M. Anesthetic management of a patient presenting with eclampsia. Anesth. Essays Res., 2013, 7(3), 307-312.
[http://dx.doi.org/10.4103/0259-1162.123214] [PMID: 25885974]
[50]
Lu, J.F.; Nightingale, C.H. Magnesium Sulfate in Eclamp-sia and Pre-Eclampsia. Clin. Pharmacokinet., 2000, 38(4), 305-314.
[http://dx.doi.org/10.2165/00003088-200038040-00002] [PMID: 10803454]
[51]
Sibai, B.M.; Taslimi, M.; Abdella, T.N.; Brooks, T.F.; Spinnato, J.A.; Anderson, G.D. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am. J. Obstet. Gynecol., 1985, 152(1), 32-37.
[http://dx.doi.org/10.1016/S0002-9378(85)80171-X] [PMID: 3993711]
[52]
Cui, Y.; Wang, W.; Dong, N.; Lou, J.; Srinivasan, D.K.; Cheng, W.; Huang, X.; Liu, M.; Fang, C.; Peng, J.; Chen, S.; Wu, S.; Liu, Z.; Dong, L.; Zhou, Y.; Wu, Q. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature, 2012, 484(7393), 246-250.
[http://dx.doi.org/10.1038/nature10897] [PMID: 22437503]
[53]
Yan, W.; Wu, F.; Morser, J.; Wu, Q. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc. Natl. Acad. Sci. USA, 2000, 97(15), 8525-8529.
[http://dx.doi.org/10.1073/pnas.150149097] [PMID: 10880574]
[54]
Castro, L.C.; Hobel, C.J.; Gornbein, J. Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am. J. Obstet. Gynecol., 1994, 171(6), 1642-1651.
[http://dx.doi.org/10.1016/0002-9378(94)90416-2] [PMID: 7802082]
[55]
Bouley, R. Corin: a key protein of an adaptive renal mechanism to respond to salt variation? Kidney Int., 2012, 82(1), 7-8.
[http://dx.doi.org/10.1038/ki.2012.123] [PMID: 22699378]
[56]
Zhou, Y.; Wu, Q. Role of corin and atrial natriuretic peptide in preeclampsia. Placenta, 2013, 34(2), 89-94.
[http://dx.doi.org/10.1016/j.placenta.2012.11.016] [PMID: 23211473]
[57]
Dong, N.; Zhou, T.; Zhang, Y.; Liu, M.; Li, H.; Huang, X.; Liu, Z.; Wu, Y.; Fukuda, K.; Qin, J.; Wu, Q. Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting.[Corrected]. J. Biol. Chem., 2014, 289(25), 17909-17916.
[http://dx.doi.org/10.1074/jbc.M114.551424] [PMID: 24828501]
[58]
Qi, X.; Jiang, J.; Zhu, M.; Wu, Q. Human corin isoforms with different cytoplasmic tails that alter cell surface targeting. J. Biol. Chem., 2011, 286(23), 20963-20969.
[http://dx.doi.org/10.1074/jbc.M110.217570] [PMID: 21518754]
[59]
Gadde, R. CD, D.; Sheela, S. Placental Protein 13. J. Circ.Biomarkers, 2018, 7184945441878615.
[http://dx.doi.org/10.1177/1849454418786159]
[60]
Kliman, H.J.; Sammar, M.; Grimpel, Y.I.; Lynch, S.K.; Milano, K.M.; Pick, E.; Bejar, J.; Arad, A.; Lee, J.J.; Meiri, H.; Gonen, R. Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia. Reprod. Sci., 2012, 19(1), 16-30.
[http://dx.doi.org/10.1177/1933719111424445] [PMID: 21989657]
[61]
Chafetz, I.; Kuhnreich, I.; Sammar, M.; Tal, Y.; Gibor, Y.; Meiri, H.; Cuckle, H.; Wolf, M. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am. J. Obstet. Gynecol., 2007, 197(1), 35.e1-35.e7.
[http://dx.doi.org/10.1016/j.ajog.2007.02.025] [PMID: 17618748]
[62]
Sekizawa, A.; Purwosunu, Y.; Yoshimura, S.; Nakamura, M.; Shimizu, H.; Okai, T.; Rizzo, N.; Farina, A. PP13 mRNA expression in trophoblasts from preeclamptic placentas. Reprod. Sci., 2009, 16(4), 408-413.
[http://dx.doi.org/10.1177/1933719108328615] [PMID: 19087972]
[63]
Akolekar, R.; Syngelaki, A.; Beta, J.; Kocylowski, R.; Nicolaides, K.H. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat. Diagn., 2009, 29(12), 1103-1108.
[http://dx.doi.org/10.1002/pd.2375] [PMID: 19777530]
[64]
Shimizu, H.; Sekizawa, A.; Purwosunu, Y.; Nakamura, M.; Farina, A.; Rizzo, N.; Okai, T. PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia. Prenat. Diagn., 2009, 29(13), 1231-1236.
[http://dx.doi.org/10.1002/pd.2380] [PMID: 19813218]
[65]
Yoneyama, Y.; Suzuki, S.; Sawa, R.; Yoneyama, K.; Power, G.G.; Araki, T. Increased plasma adenosine concentrations and the severity of preeclampsia. Obstet. Gynecol., 2002, 100(6), 1266-1270.
[PMID: 12468172]
[66]
Iriyama, T.; Xia, Y. Placental Adenosine Signaling in the Pathophysiology of Preeclampsia. In: Preeclampsia. Comprehensive Gynecology and Obstetrics.Shigeru ; Saito, , Ed.; Springer: Singapore, 2018; pp. 99-112.
[http://dx.doi.org/10.1007/978-981-10-5891-2_6]
[67]
Venkatesha, S.; Toporsian, M.; Lam, C.; Hanai, J.; Mammoto, T.; Kim, Y.M.; Bdolah, Y.; Lim, K-H.; Yuan, H-T.; Libermann, T.A.; Stillman, I.E.; Roberts, D.; D’Amore, P.A.; Epstein, F.H.; Sellke, F.W.; Romero, R.; Sukhatme, V.P.; Letarte, M.; Karumanchi, S.A. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med., 2006, 12(6), 642-649.
[http://dx.doi.org/10.1038/nm1429] [PMID: 16751767]
[68]
Aksoy, H.; Kumtepe, Y.; Akçay, F.; Yildirim, A.K. Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia. Clin. Exp. Med., 2002, 2(1), 39-43.
[http://dx.doi.org/10.1007/s102380200005] [PMID: 12049188]
[69]
Cetin, I.; Cozzi, V.; Pasqualini, F.; Nebuloni, M.; Garlanda, C.; Vago, L.; Pardi, G.; Mantovani, A. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am. J. Obstet. Gynecol., 2006, 194(5), 1347-1353.
[http://dx.doi.org/10.1016/j.ajog.2005.11.018] [PMID: 16647920]
[70]
Grill, S.; Rusterholz, C.; Zanetti-Dällenbach, R.; Tercanli, S.; Holzgreve, W.; Hahn, S.; Lapaire, O. Potential markers of preeclampsia--a review. Reprod. Biol. Endocrinol., 2009, 7(1), 70.
[http://dx.doi.org/10.1186/1477-7827-7-70] [PMID: 19602262]
[71]
McCarthy, F.P.; Ryan, R.M.; Chappell, L.C. Prospective biomarkers in preterm preeclampsia: a review. Pregnancy Hypertens., 2018, 14, 72-78.
[http://dx.doi.org/10.1016/j.preghy.2018.03.010] [PMID: 30527122]
[72]
Tsai, S.; Hardison, N.E.; James, A.H.; Motsinger-Reif, A.A.; Bischoff, S.R.; Thames, B.H.; Piedrahita, J.A. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta, 2011, 32(2), 175-182.
[http://dx.doi.org/10.1016/j.placenta.2010.11.014] [PMID: 21183218]
[73]
Vadillo-Ortega, F.; Perichart-Perera, O.; Espino, S.; Avila-Vergara, M.A.; Ibarra, I.; Ahued, R.; Godines, M.; Parry, S.; Macones, G.; Strauss, J.F. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ, 2011, 342, d2901.
[http://dx.doi.org/10.1136/bmj.d2901] [PMID: 21596735]
[74]
Chaiworapongsa, T.; Chaemsaithong, P.; Korzeniewski, S.J.; Yeo, L.; Romero, R. Pre-eclampsia part 2: prediction, prevention and management. Nat. Rev. Nephrol., 2014, 10(9), 531-540.
[http://dx.doi.org/10.1038/nrneph.2014.103] [PMID: 25003612]
[75]
Venkatesha, S.; Toporsian, M.; Lam, C.; Hanai, J.; Mammoto, T.; Kim, Y.M.; Bdolah, Y.; Lim, K-H.; Yuan, H-T.; Libermann, T.A.; Stillman, I.E.; Roberts, D.; D’Amore, P.A.; Epstein, F.H.; Sellke, F.W.; Romero, R.; Sukhatme, V.P.; Letarte, M.; Karumanchi, S.A. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med., 2006, 12(6), 642-649.
[http://dx.doi.org/10.1038/nm1429] [PMID: 16751767]
[76]
Mol, B.W.J.; Roberts, C.T.; Thangaratinam, S.; Magee, L.A.; de Groot, C.J.M.; Hofmeyr, G.J. Pre-eclampsia. Lancet, 2016, 387(10022), 999-1011.
[http://dx.doi.org/10.1016/S0140-6736(15)00070-7] [PMID: 26342729]
[77]
Steinberg, G.; Khankin, E.V.; Karumanchi, S.A. Angiogenic factors and preeclampsia. Thromb. Res., 2009, 123(Suppl. 2), S93-S99.
[http://dx.doi.org/10.1016/S0049-3848(09)70020-9] [PMID: 19217486]
[78]
Kanasaki, K.; Palmsten, K.; Sugimoto, H.; Ahmad, S.; Hamano, Y.; Xie, L.; Parry, S.; Augustin, H.G.; Gattone, V.H.; Folkman, J.; Strauss, J.F.; Kalluri, R. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature, 2008, 453(7198), 1117-1121.
[http://dx.doi.org/10.1038/nature06951] [PMID: 18469803]
[79]
Chaiworapongsa, T.; Chaemsaithong, P.; Yeo, L.; Romero, R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat. Rev. Nephrol., 2014, 10(8), 466-480.
[http://dx.doi.org/10.1038/nrneph.2014.102] [PMID: 25003615]
[80]
Eskenazi, B.; Fenster, L.; Sidney, S. A multivariate analysis of risk factors for preeclampsia. JAMA, 1991, 266(2), 237-241.
[http://dx.doi.org/10.1001/jama.1991.03470020063033] [PMID: 2056625]
[81]
Conde-Agudelo, A.; Belizán, J.M.; Lindmark, G. Maternal morbidity and mortality associated with multiple gestations. Obstet. Gynecol., 2000, 95(6 Pt 1), 899-904.
[http://dx.doi.org/10.1097/00006250-200006000-00022] [PMID: 10831988]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 25
Year: 2019
Page: [4786 - 4798]
Pages: 13
DOI: 10.2174/0929867326666190228115423
Price: $58

Article Metrics

PDF: 15
HTML: 1